6998 fundamentals
An in-depth look to GENOR BIOPHARMA HLDGS LTD operating, investing, and financing activities
6998 free cash flow for H1 24 is -160.16 M HKD. For 2023, 6998 free cash flow was -470.9 M HKD and operating cash flow was -469.76 M HKD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM